HBV Special Interest Group
HBV Special Interest Group
The HBV Special Interest Group (SIG) is linked to the Viral CRN topic area. The SIG lead is Dr Ahmed Elsharkawy of University Hospitals Birmingham (elected February 2022). The first meeting of the SIG was held in June 2018. If anyone wishes to join the group please contact the BASL secretariat on firstname.lastname@example.org.
Define a strategic approach to recruit patients from centres across the UK encompassing the spectrum of HBV disease phases, to determine mechanisms underlying disease progression and treatment response, and to identify novel biomarkers in future hypothesis-driven research.
Document long-term clinical outcomes for the cohort, using both patient clinical records, and other linkable data sources, including routine laboratory surveillance, NHS Health and Social Care Information Centre datasets, and death and cancer registries. This would provide critical data on disease burden, natural history and use of NHS resources, and identify areas for intervention.
Involve patient and public representatives in a meaningful way to support investigators on study design, development and implementation, to ensure effective Patient-Public Involvement and Engagement.
Annual report 2018-19 - Download Annual report_2018-19_HBV SIG.pdf.
1st meeting - 28 June 2018
Presentation on HBV research in the UK, Will Irving, University of Nottingham - Download HBV Research UK.pdf.
Presentation on Hepatitis B priority areas, Sema Mandal and Samreen Ijaz, PHE - Download Hepatitis B priority areas.pdf.
Presentation on the HBV pipeline and what the SIG can offer, Geoff Dusheiko, Kings College Hospital - Download The HBV pipeline and what the SIG can offer.pdf.
Presentation on HBV immunological research, Salim Khakoo, University of Southampton - Download HBV immunological research.pdf.
Presentation on HBV biomarkers, Ivana Carey, King’s College Hospital - Download HBV biomarkers.pdf.
2nd meeting - 31 January 2019
Meeting report - Download The HBV SIG Jan 2019_Report.pdf.
3rd meeting - 11 July 2019
Presentation on attempts to secure funds for STORM HBV Consortium, John McLauchlan, Centre for Virus Research, Glasgow - Download Attempts to secure funds for STORM HBV Consortium.pdf.
Presentation on biomarkers of HBV transcriptional activity, Ivana Carey, Kings College Hospital, London - Download Biomarkers of HBV transcriptional activity.pdf.
Presentation on pitfalls of HBV DNA testing during NUC therapy, Anna Maria Geretti, University of Liverpool - Download Pitfalls of HBV DNA testing during NUC therapy.pdf.
Presentation on WHO hepatitis B elimination targets: How are we doing?, Ruth Simmons, PHE - Download WHO hepatitis B elimination targets _How are we doing.pdf
News & Meetings - BVHG & HBV SIG Webinar
The first BVHG and HBV SIG webinar of 2021 took place on Friday 22nd January.
Watch the video of the webinar here > https://youtu.be/7AsYEknbYHg